Valuation: Optiscan Imaging Limited

Market Cap 125M 87.7M 76.67M 70.73M 65.02M 123M 8.44B 844M 331M 4.12B 329M 322M 14.22B P/E 2024
-31.8x
P/E 2025 -14.5x
Enterprise Value 122M 85.55M 74.79M 69M 63.42M 120M 8.23B 824M 323M 4.02B 321M 314M 13.87B EV / Sales 2024
62.1x
EV / Sales 2025 23.8x
Free-Float
36.32%
Yield 2024 *
-
Yield 2025 -
1 week+3.33%
Current month+29.17%
1 month+24.00%
3 months+29.17%
6 months+72.22%
Current year+55.00%
1 week 0.15
Extreme 0.147
0.16
1 month 0.12
Extreme 0.12
0.16
Current year 0.08
Extreme 0.08
0.16
1 year 0.08
Extreme 0.079
0.16
3 years 0.07
Extreme 0.071
0.26
5 years 0.07
Extreme 0.071
0.29
10 years 0.01
Extreme 0.013
0.47
Manager TitleAgeSince
Chief Executive Officer - 2021-12-12
Director of Finance/CFO - 2025-03-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2021-02-09
Chairman - 2021-04-18
Director/Board Member - 2021-05-05
Date Insider Type Main position Quantity % Market Cap.
05-21Sell

Director

-3,000,000 0.2873%
01-14Free

Chairman

419,094 0.0401%
01-14Free

Chief Executive Officer

6,157,719 0.5897%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+3.33%+47.62%+76.14% 113M
-1.10%+5.01%-12.69%-21.09% 13.34B
-1.89%-13.40%+57.84%-2.40% 4.39B
+2.39%-2.93%+61.70%+104.66% 1.17B
+3.33%+3.17%-32.66%-60.63% 1.17B
+1.60%+3.85%-37.97%-46.34% 1.1B
+1.62%+3.58%-45.15% - 901M
-1.19%-12.23%+108.81%+109.54% 551M
-2.12%+1.22%+35.08% - 318M
+1.37%+3.82%-52.35%+231.87% 257M
Average +0.40%-0.09%+13.02%+48.97% 2.33B
Weighted average by Cap. -0.60%-2.06%+4.25%-7.36%

Financials

2024 2025
Net sales 2.99M 2.09M 1.83M 1.69M 1.55M 2.94M 201M 20.12M 7.9M 98.29M 7.85M 7.68M 339M 3.72M 2.61M 2.28M 2.1M 1.93M 3.66M 251M 25.1M 9.85M 123M 9.79M 9.57M 423M
Net income -6.06M -4.24M -3.71M -3.42M -3.14M -5.96M -408M -40.84M -16.03M -199M -15.93M -15.58M -688M -6.31M -4.42M -3.86M -3.56M -3.28M -6.21M -425M -42.54M -16.69M -208M -16.59M -16.23M -716M
Net Debt -11.01M -7.71M -6.74M -6.22M -5.71M -10.83M -742M -74.2M -29.12M -362M -28.94M -28.31M -1.25B -3.07M -2.15M -1.88M -1.73M -1.59M -3.02M -207M -20.69M -8.12M -101M -8.07M -7.89M -348M
Logo Optiscan Imaging Limited
Optiscan Imaging Limited is a commercial stage medical technology company. It creates a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It is engaged in development, manufacturing, and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level. Its products include InVue, InForm, InVivage, ViewnVivo and InSpecta. ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand. InVivage is an intra-oral digital endomicroscope.
Employees
9
Date Price Change Volume
26-07-15 A$0.1550 0.00% 153,558
26-07-14 A$0.1550 0.00% 99,611
26-07-13 A$0.1550 0.00% 743,716
26-07-10 A$0.1550 +3.33% 601,131
26-07-09 A$0.1500 -3.23% 197,390